Ranodhi N Serrao
Examiner (ID: 2922, Phone: (571)272-7967 , Office: P/2444 )
Most Active Art Unit | 2444 |
Art Unit(s) | 2141, 2441, 2444 |
Total Applications | 770 |
Issued Applications | 619 |
Pending Applications | 47 |
Abandoned Applications | 100 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 17228692
[patent_doc_number] => 20210355248
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-18
[patent_title] => AN IMPROVED PROCESS FOR THE PREPARATION OF SUGAMMADEX SODIUM AND ITS NOVEL POLYMORPHIC FORM
[patent_app_type] => utility
[patent_app_number] => 17/278296
[patent_app_country] => US
[patent_app_date] => 2019-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5379
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17278296
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/278296 | Process for the preparation of Sugammadex sodium and its novel polymorphic form | Sep 17, 2019 | Issued |
Array
(
[id] => 16492359
[patent_doc_number] => 10858384
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-08
[patent_title] => Synthetic molecule constructs
[patent_app_type] => utility
[patent_app_number] => 16/571526
[patent_app_country] => US
[patent_app_date] => 2019-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 20
[patent_no_of_words] => 25027
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16571526
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/571526 | Synthetic molecule constructs | Sep 15, 2019 | Issued |
Array
(
[id] => 17052161
[patent_doc_number] => 20210261595
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-26
[patent_title] => PRODUCTION METHOD FOR GUANOSINE DERIVATIVE HAVING FLUORINE ATOM-CONTAINING FUNCTIONAL GROUP AT POSITION 8 AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/275083
[patent_app_country] => US
[patent_app_date] => 2019-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4465
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17275083
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/275083 | Production method for guanosine derivative having fluorine atom-containing functional group at position 8 and application thereof | Aug 28, 2019 | Issued |
Array
(
[id] => 16605935
[patent_doc_number] => 10906927
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-02-02
[patent_title] => Steviol glycoside compounds, compositions for oral ingestion or use, and method for enhancing steviol glycoside solubility
[patent_app_type] => utility
[patent_app_number] => 16/553200
[patent_app_country] => US
[patent_app_date] => 2019-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 19
[patent_no_of_words] => 16951
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16553200
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/553200 | Steviol glycoside compounds, compositions for oral ingestion or use, and method for enhancing steviol glycoside solubility | Aug 27, 2019 | Issued |
Array
(
[id] => 15553361
[patent_doc_number] => 20200061092
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-27
[patent_title] => METHODS AND COMPOSITIONS FOR TREATING DISORDERS ASSOCIATED WITH MUSCLE WEAKNESS
[patent_app_type] => utility
[patent_app_number] => 16/549986
[patent_app_country] => US
[patent_app_date] => 2019-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16116
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16549986
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/549986 | METHODS AND COMPOSITIONS FOR TREATING DISORDERS ASSOCIATED WITH MUSCLE WEAKNESS | Aug 22, 2019 | Abandoned |
Array
(
[id] => 16915800
[patent_doc_number] => 20210188892
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-24
[patent_title] => NOVEL EPOXIDE POLYENE AMPHOTERIC MACROLIDE AND PROCESS FOR PURIFYING NATAMYCIN
[patent_app_type] => utility
[patent_app_number] => 17/268252
[patent_app_country] => US
[patent_app_date] => 2019-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4591
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17268252
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/268252 | Epoxide polyene amphoteric macrolide and process for purifying natamycin | Aug 14, 2019 | Issued |
Array
(
[id] => 17022286
[patent_doc_number] => 20210246157
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-12
[patent_title] => CAMPTOTHECIN DERIVATIVES AND PREPARATION METHODS AND APPLICATIONS THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/270063
[patent_app_country] => US
[patent_app_date] => 2019-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10699
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17270063
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/270063 | Camptothecin derivatives and preparation methods and applications thereof | Aug 14, 2019 | Issued |
Array
(
[id] => 16991787
[patent_doc_number] => 20210230207
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => NOVEL ALL-TRANS POLYENE AMPHOTERIC MACROLIDE
[patent_app_type] => utility
[patent_app_number] => 17/267790
[patent_app_country] => US
[patent_app_date] => 2019-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4591
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17267790
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/267790 | All-trans polyene amphoteric macrolide | Aug 14, 2019 | Issued |
Array
(
[id] => 17156103
[patent_doc_number] => 20210317154
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-14
[patent_title] => METHOD FOR PRODUCING SUGAR FATTY ACID ESTER BY TRANSESTERIFICATION REACTION
[patent_app_type] => utility
[patent_app_number] => 17/265666
[patent_app_country] => US
[patent_app_date] => 2019-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4107
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17265666
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/265666 | Method for producing sugar fatty acid ester by transesterification reaction | Aug 8, 2019 | Issued |
Array
(
[id] => 15405349
[patent_doc_number] => 20200022996
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-23
[patent_title] => NUTRITIONAL FORMULATIONS INCLUDING HUMAN MILK OLIGOSACCHARIDES AND ANTIOXIDANTS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/531849
[patent_app_country] => US
[patent_app_date] => 2019-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16769
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 166
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16531849
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/531849 | Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof | Aug 4, 2019 | Issued |
Array
(
[id] => 16867675
[patent_doc_number] => 20210161142
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-03
[patent_title] => Pesticides and Methods of Use Thereof
[patent_app_type] => utility
[patent_app_number] => 17/265787
[patent_app_country] => US
[patent_app_date] => 2019-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13523
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 169
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17265787
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/265787 | Pesticides and Methods of Use Thereof | Aug 1, 2019 | Pending |
Array
(
[id] => 15430825
[patent_doc_number] => 20200029595
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-30
[patent_title] => SACCHARIDES AND SACCHARIDE COMPOSTIONS AND MIXTURES
[patent_app_type] => utility
[patent_app_number] => 16/529986
[patent_app_country] => US
[patent_app_date] => 2019-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11422
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16529986
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/529986 | SACCHARIDES AND SACCHARIDE COMPOSTIONS AND MIXTURES | Aug 1, 2019 | Abandoned |
Array
(
[id] => 18801317
[patent_doc_number] => 11834469
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-12-05
[patent_title] => AMP-activated protein kinase activating compounds and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/259892
[patent_app_country] => US
[patent_app_date] => 2019-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9313
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17259892
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/259892 | AMP-activated protein kinase activating compounds and uses thereof | Aug 1, 2019 | Issued |
Array
(
[id] => 15407951
[patent_doc_number] => 20200024297
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-23
[patent_title] => SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/528414
[patent_app_country] => US
[patent_app_date] => 2019-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 77041
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16528414
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/528414 | Substituted nucleosides, nucleotides and analogs thereof | Jul 30, 2019 | Issued |
Array
(
[id] => 15454567
[patent_doc_number] => 20200040108
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-06
[patent_title] => PROCESS FOR MAKING A CONSUMER PRODUCT COMPRISING MODIFIED POLYSACCHARIDES
[patent_app_type] => utility
[patent_app_number] => 16/525629
[patent_app_country] => US
[patent_app_date] => 2019-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5260
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16525629
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/525629 | PROCESS FOR MAKING A CONSUMER PRODUCT COMPRISING MODIFIED POLYSACCHARIDES | Jul 29, 2019 | Abandoned |
Array
(
[id] => 17005471
[patent_doc_number] => 20210236632
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-05
[patent_title] => USE OF TOLL-LIKE RECEPTOR 2 (TLR-2) AGONIST FOR MODULATING HUMAN IMMUNE RESPONSE
[patent_app_type] => utility
[patent_app_number] => 17/263515
[patent_app_country] => US
[patent_app_date] => 2019-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49312
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -141
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17263515
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/263515 | USE OF TOLL-LIKE RECEPTOR 2 (TLR-2) AGONIST FOR MODULATING HUMAN IMMUNE RESPONSE | Jul 25, 2019 | Pending |
Array
(
[id] => 17005471
[patent_doc_number] => 20210236632
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-05
[patent_title] => USE OF TOLL-LIKE RECEPTOR 2 (TLR-2) AGONIST FOR MODULATING HUMAN IMMUNE RESPONSE
[patent_app_type] => utility
[patent_app_number] => 17/263515
[patent_app_country] => US
[patent_app_date] => 2019-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49312
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -141
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17263515
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/263515 | USE OF TOLL-LIKE RECEPTOR 2 (TLR-2) AGONIST FOR MODULATING HUMAN IMMUNE RESPONSE | Jul 25, 2019 | Pending |
Array
(
[id] => 17005471
[patent_doc_number] => 20210236632
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-05
[patent_title] => USE OF TOLL-LIKE RECEPTOR 2 (TLR-2) AGONIST FOR MODULATING HUMAN IMMUNE RESPONSE
[patent_app_type] => utility
[patent_app_number] => 17/263515
[patent_app_country] => US
[patent_app_date] => 2019-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49312
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -141
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17263515
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/263515 | USE OF TOLL-LIKE RECEPTOR 2 (TLR-2) AGONIST FOR MODULATING HUMAN IMMUNE RESPONSE | Jul 25, 2019 | Pending |
Array
(
[id] => 17141670
[patent_doc_number] => 20210309682
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-07
[patent_title] => PROCESS FOR PREPARING MANNOSE DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 17/263012
[patent_app_country] => US
[patent_app_date] => 2019-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6717
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17263012
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/263012 | Process for preparing mannose derivatives | Jul 25, 2019 | Issued |
Array
(
[id] => 17110061
[patent_doc_number] => 20210290658
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-23
[patent_title] => HIGHLY SULFATED FUCANS FOR THE TREATMENT OF FIBROUS ADHESIONS
[patent_app_type] => utility
[patent_app_number] => 17/260275
[patent_app_country] => US
[patent_app_date] => 2019-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19419
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17260275
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/260275 | Highly sulfated fucans for the treatment of fibrous adhesions | Jul 23, 2019 | Issued |